StockWatch
·
Specialty Chemicals
Acquisitions18 Aug 2026, 07:40 pm

Jubilant Ingrevia to Acquire 40% Stake in Zettaone for ₹189.2 Cr

AI Summary

Jubilant Ingrevia Limited has approved entering into a binding term sheet to acquire a 40% strategic equity stake in Zettaone Technologies India Private Limited for ₹189.2 crore. This acquisition, expected to be completed in two tranches by September 2027, will make Zettaone an associate company. The move aligns with Jubilant Ingrevia's growth strategy, aiming to establish a strong platform in the Electronics Development and Manufacturing Services (EDMS) space. It will enable the company to offer integrated value propositions in the electronics and semiconductor sectors, leveraging its existing manufacturing and customer-centric capabilities. Zettaone, an integrated electronics design and manufacturing platform, reported revenues of ₹98.1 Cr in FY26.

Key Highlights

  • Jubilant Ingrevia to acquire 40% stake in Zettaone Technologies.
  • Acquisition cost is ₹189.2 crore, payable in cash.
  • Zettaone will become an associate company post-acquisition.
  • Strategic move into Electronics Development and Manufacturing Services (EDMS).
  • Transaction completion expected by September 2027.